Elysium gets ChromaDex, Dartmouth vitamin patents invalidated
23-09-2021
Ukrainians plead guilty to trafficking counterfeit drugs into the US
20-07-2020
stock_colors / iStockphoto.com
The US Department of Justice (DoJ) has asked for an injunction to stop a Louisiana-based drug and dietary supplement manufacturer from distributing misbranded and unapproved new drugs and dietary supplements.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Department of Justice, FDA, US District Court for the Western District of Louisiana, Pick and Pay, Cili Minerals, FDCA, drugs, supplements, misbranding,
